Literature DB >> 7872325

Outcome of polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients.

L Kiernan1, F O Finkelstein, A S Kliger, N Gorban-Brennan, P Juergensen, A Mooraki, E Brown.   

Abstract

Polymicrobial peritonitis is a relatively uncommon, but potentially serious complication that develops in continuous ambulatory peritoneal dialysis (CAPD) patients. Its cause and optimal management remain controversial. The authors reviewed the frequency and natural history of polymicrobial peritonitis in 432 CAPD patients. Of 1,405 episodes of peritonitis, 80 were polymicrobial (6%). Patients with polymicrobial peritonitis were similar to all CAPD patients in age, gender, race, and underlying renal disease. Diabetes mellitus, human immunodeficiency virus (HIV) status, and clinically apparent gastrointestinal disease did not predisposes patients to polymicrobial peritonitis. Thirty days after the polymicrobial peritonitis, 64 patients remained on CAPD (80%), and at 180 days 48 patients continued CAPD. Prior exit-site infections were present in 12 patients (14%) with polymicrobial peritonitis. Only 22% of patients required catheter removal to treat the infection. We conclude that polymicrobial peritonitis accounts for 6% of the total episodes of peritonitis; diabetes, HIV infection, and underlying gastrointestinal disease are not more prevalent in patients with multiorganism infections. Most patients continue CAPD therapy at 30 and 180 days after the episode of polymicrobial peritonitis.

Entities:  

Mesh:

Year:  1995        PMID: 7872325     DOI: 10.1016/0272-6386(95)90109-4

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  9 in total

1.  Providencia rettgeri peritonitis in a patient on peritoneal dialysis with perforated appendicitis.

Authors:  Tom Kai Ming Wang; Yeri Ahn; Joanna Dunlop
Journal:  Perit Dial Int       Date:  2014 Jul-Aug       Impact factor: 1.756

2.  Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity.

Authors:  Brian M Peters; Mairi C Noverr
Journal:  Infect Immun       Date:  2013-04-01       Impact factor: 3.441

Review 3.  Peritoneal dialysis. Prevention and control of infection.

Authors:  R Gokal
Journal:  Drugs Aging       Date:  2000-10       Impact factor: 3.923

4.  Staphylococcus aureus serves as an iron source for Pseudomonas aeruginosa during in vivo coculture.

Authors:  Lauren M Mashburn; Amy M Jett; Darrin R Akins; Marvin Whiteley
Journal:  J Bacteriol       Date:  2005-01       Impact factor: 3.490

5.  Long-term outcome of continuous ambulatory peritoneal dialysis (CAPD) peritonitis: surgery can be avoided.

Authors:  A Al-Allak; R Jones; R Stiff; D Dharmasena; G Morris-Stiff
Journal:  Ann R Coll Surg Engl       Date:  2008-12-19       Impact factor: 1.891

6.  Peritonitis before Peritoneal Dialysis Training: Analysis of Causative Organisms, Clinical Outcomes, Risk Factors, and Long-Term Consequences.

Authors:  Terry King-Wing Ma; Kai Ming Chow; Bonnie Ching-Ha Kwan; Wing Fai Pang; Chi Bon Leung; Philip Kam-Tao Li; Cheuk Chun Szeto
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-06       Impact factor: 8.237

7.  Clinical and microbiological characteristics of peritoneal dialysis-related peritonitis caused by Escherichia coli in southern Taiwan.

Authors:  Wei-Hung Lin; Chin-Chung Tseng; An-Bang Wu; Yu-Tzu Chang; Te-Hui Kuo; Jo-Yen Chao; Ming-Cheng Wang; Jiunn-Jong Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-21       Impact factor: 3.267

8.  TatC-dependent translocation of pyoverdine is responsible for the microbial growth suppression.

Authors:  Yeji Lee; Yong-Jae Kim; Jung-Hoon Lee; Hyung Eun Yu; Kiho Lee; Shouguang Jin; Un-Hwan Ha
Journal:  J Microbiol       Date:  2016-02-02       Impact factor: 3.422

Review 9.  Treatment and outcome of CPD-associated peritonitis.

Authors:  Laura Troidle; Fred Finkelstein
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-04-06       Impact factor: 3.944

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.